デフォルト表紙
市場調査レポート
商品コード
1601283

リスクベースモニタリングソフトウェア市場:機能、提供形態、エンドユーザー別-2025-2030年の世界予測

Risk-based Monitoring Software Market by Function (Centralized Monitoring, Reduced Monitoring, Remote Monitoring), Delivery Mode (Cloud-Based, Licensed Enterprise, Web-Based), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 192 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
リスクベースモニタリングソフトウェア市場:機能、提供形態、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

リスクベースモニタリングソフトウェア市場は、2023年に4億938万米ドルと評価され、2024年には4億5,294万米ドルに達すると予測され、CAGR 10.91%で成長し、2030年には8億4,513万米ドルになると予測されています。

リスクベースモニタリング(RBM)ソフトウェアは、重要なデータに優先順位を付け、潜在的なリスク要因に基づいてモニタリングの取り組みを調整することで、組織の臨床試験処理方法に革命をもたらします。RBMソフトウェアは、リソースの効率的な割り当てを容易にし、大規模臨床試験において極めて重要な時間とコストの両方を最適化します。臨床試験の複雑化と規模拡大、プロトコールコンプライアンスの義務化、リアルタイムのデータ監視を必要とする適応性の高い試験デザインへのシフトを考えると、RBMは不可欠です。用途は製薬部門にとどまらず、バイオテクノロジー、医療機器産業、ヘルスケア機関などにも広がっており、最終用途の拡大を反映しています。この市場の主な発展要因には、研究開発費の増加、医薬品開発サイクルの短縮の必要性、規制当局の監視強化などがあります。COVID-19の流行は臨床試験全体のデジタル変革に拍車をかけ、遠隔モニタリング用のRBMソフトウェアの展開を後押ししています。高度な予測分析とAI主導のリスク評価を提供し、臨床試験管理の精度と効率の向上を可能にするソフトウェアの強化にビジネスチャンスがあります。さらに、デジタルヘルスソリューションの導入が進む新興市場への進出は、大きな成長の可能性を約束します。とはいえ、ソフトウェアの導入コストの高さや、従来のモニタリングスタッフを新しい技術に適応させるための広範なトレーニングの必要性など、課題も残っています。また、デジタル・プラットフォームへの依存度が高まるにつれ、データ漏洩に対する懸念が強まっており、データ・セキュリティも限界のひとつとなっています。これらの課題を克服し、イノベーションを推進するためには、RBMと他の臨床試験管理ツールを組み合わせた統合プラットフォームへの投資が極めて重要になる可能性があります。ブロックチェーン技術の革新は、透明性とデータセキュリティを強化し、市場の主要な懸念に対処する可能性があります。RBMソフトウェア市場は、急速な技術進歩と規制のダイナミクスによって特徴付けられ、適応的な戦略が必要となります。企業は、競争力を維持し、個別化医療や分散型臨床試験における新たな機会を活用するために、テクノロジー企業や医療提供者との強固なパートナーシップに注力すべきです。

主な市場の統計
基準年[2023] 4億938万米ドル
予測年[2024] 4億5,294万米ドル
予測年[2030] 8億4,513万米ドル
CAGR(%) 10.91%

市場力学:急速に進化するリスクベースモニタリングソフトウェア市場の主要市場インサイトを公開

リスクベースモニタリングソフトウェア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • リスクベースモニタリングソフトウェアを使用した臨床試験モニタリングへの積極的なアプローチの必要性
    • 新しい治療法や薬剤の有効性を判断するための臨床試験数の増加
    • 臨床試験の品質と安全性に関する政府からの助成金と規制の遵守
  • 市場抑制要因
    • RBMソフトウェアの複雑な実装とRBMソフトウェアに対する組織の消極性
  • 市場機会
    • リスクベースモニタリングソフトウェアにおける技術の進歩
    • 製薬企業によるエンド・ツー・エンド・サービスのアウトソーシング傾向の高まり
  • 市場の課題
    • RBMソフトウェアに関連するデータセキュリティとプライバシーに関する懸念

ポーターの5つの力:リスクベースモニタリングソフトウェア市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:リスクベースモニタリングソフトウェア市場における外部からの影響の把握

外部マクロ環境要因は、リスクベースモニタリングソフトウェア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析リスクベースモニタリングソフトウェア市場における競合情勢の把握

リスクベースモニタリングソフトウェア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスリスクベースモニタリングソフトウェア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、リスクベースモニタリングソフトウェア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています:

1.市場の浸透度:業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • リスクベースモニタリングソフトウェアを使用した臨床試験のモニタリングに対する積極的なアプローチの必要性
      • 新しい治療法や薬の有効性を判断するための臨床試験の増加
      • 臨床試験の品質と安全性に関する政府助成金と規制遵守
    • 抑制要因
      • RBMソフトウェアの複雑な実装と組織のRBMソフトウェアに対する抵抗
    • 機会
      • リスクベースモニタリングソフトウェアにおける技術的進歩
      • 製薬会社によるエンドツーエンドのアウトソーシングの傾向が増加
    • 課題
      • RBMソフトウェアに関連するデータセキュリティとプライバシーに関する懸念
  • 市場セグメンテーション分析
    • 機能:遠隔監視活動のためのリスクベースの監視ソフトウェアの出現
    • 配信モード:リスクベースの監視ソフトウェアのクラウドベースの配信の進歩
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境
  • 顧客のカスタマイズ

第6章 リスクベースモニタリングソフトウェア市場:機能別

  • 集中監視
  • 監視の削減
  • リモートモニタリング
  • トリガー監視

第7章 リスクベースモニタリングソフトウェア市場配送方法別

  • クラウドベース
  • ライセンス企業
  • ウェブベース

第8章 リスクベースモニタリングソフトウェア市場:エンドユーザー別

  • 契約調査機関
  • 医療機器企業
  • 製薬・バイオ医薬品企業

第9章 南北アメリカのリスクベースモニタリングソフトウェア市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のリスクベースモニタリングソフトウェア市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのリスクベースモニタリングソフトウェア市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • Cloudbyz、臨床調査を効率化し、新しい治療法の発売を加速する画期的な電子データキャプチャソリューションを発表
    • Clario、臨床試験向けクラウドベースの画像ビューアをリリース
    • ClinChoiceがCROMSOURCEを買収し、世界のプレゼンスを拡大
    • Scrut Automation、Massmutual Venturesから750万米ドルを調達
    • EMAは臨床試験の生データの分析に関するパイロットプロジェクトを開始しました。
    • Q2ソリューションズ、タッソと共同で革新的なセルフコレクション安全ラボパネルを発表
    • メディデータは、10社の医療技術イノベーターの参加によりセンサークラウドネットワークを急速に拡大すると発表しました。
    • メディデータ、臨床試験監視における重要な問題に対処するための新しい臨床オペレーションテクノロジーを発表
    • ノボテックとメディデータは、臨床調査の進歩を継続するために提携を拡大しました。
    • Veeva Vault CTMSにより150社以上の企業が臨床試験を積極的に管理できるようになりました
    • TCSがリスクベースの監視ソリューションを発表
    • ThreadとAmazon Web ServicesがクラウドベースのAI駆動型分散型臨床試験テクノロジーを導入し、臨床調査を近代化

企業一覧

  • Anju Software, Inc.
  • ArisGlobal LLC
  • CGI Inc.
  • Change Healthcare LLC
  • Clario
  • CluePoints S.A.
  • Dassault Systemes S.E.
  • DATATRAK International, Inc.
  • DSG, Inc.
  • eClinical Solutions LLC
  • ICON PLC
  • Infosys Limited
  • International Business Machines Corporation
  • IQVIA Inc.
  • JMP Statistical Discovery LLC
  • Laboratory Corporation of America Holdings
  • LexisNexis Risk Solutions Group
  • MasterControl Solutions Inc.
  • Mednet
  • Microsoft Corporation
  • Octalsoft by Glorant, LLC
  • Oracle Corporation
  • Parexel International Corporation
  • Quanticate International Limited
  • Scrut Automation
  • Securitas AB
  • Signant Health
  • Sphera Solutions, Inc.
  • TATA Consultancy Services Limited
  • Veeva Systems Inc.
  • Wipro Limited
図表

LIST OF FIGURES

  • FIGURE 1. RISK-BASED MONITORING SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. RISK-BASED MONITORING SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. RISK-BASED MONITORING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RISK-BASED MONITORING SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RISK-BASED MONITORING SOFTWARE MARKET DYNAMICS
  • TABLE 7. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY CENTRALIZED MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY REDUCED MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY TRIGGERED MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY LICENSED ENTERPRISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY WEB-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM RISK-BASED MONITORING SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. RISK-BASED MONITORING SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-F949FCDE0873

The Risk-based Monitoring Software Market was valued at USD 409.38 million in 2023, expected to reach USD 452.94 million in 2024, and is projected to grow at a CAGR of 10.91%, to USD 845.13 million by 2030.

Risk-based Monitoring (RBM) Software revolutionizes how organizations handle clinical trials by prioritizing critical data and adjusting monitoring efforts based on potential risk factors. RBM software facilitates the efficient allocation of resources, optimizing both time and costs, crucial in large-scale trials. It is imperative given the increasing complexity and size of clinical trials, mandated protocol compliance, and the shift towards more adaptive trial designs which demand real-time data oversight. Applications extend beyond the pharmaceutical sector to biotechnology, medical device industries, and healthcare organizations, reflecting its growing end-use scope. Key growth factors in this market include rising R&D expenditure, the necessity for shorter drug development cycles, and enhanced regulatory scrutiny. The COVID-19 pandemic has spurred digital transformation across clinical trials, boosting RBM software deployment for remote monitoring. Opportunities lie in software enhancements that offer advanced predictive analytics and AI-driven risk assessments, enabling greater precision and efficiency in trial management. Moreover, expansion into emerging markets, which are increasingly adopting digital health solutions, promises significant growth potential. Nonetheless, challenges persist, including high software implementation costs and the need for extensive training to adapt traditional monitoring staff to new technologies. Data security is another limitation, with the increasing reliance on digital platforms intensifying concerns over data breaches. To overcome these challenges and drive innovation, investing in integrated platforms that combine RBM with other clinical trial management tools could be pivotal. Innovations in blockchain technology could enhance transparency and data security, addressing major market concerns. The RBM software market is characterized by rapid technological advancements and regulatory dynamics, necessitating adaptive strategies. Businesses should focus on robust partnerships with technology firms and healthcare providers to stay competitive and capitalize on new opportunities in personalized medicine and decentralized trials.

KEY MARKET STATISTICS
Base Year [2023] USD 409.38 million
Estimated Year [2024] USD 452.94 million
Forecast Year [2030] USD 845.13 million
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Risk-based Monitoring Software Market

The Risk-based Monitoring Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for proactive approach to monitoring clinical trials with the use of risk-based monitoring software
    • Rising number of clinical trials to determine new form of treatment and effectiveness of drugs
    • Government grants and regulatory compliance for the quality and safety of clinical trials
  • Market Restraints
    • Complex implementation of the RBM software and organization reluctance to RBM software
  • Market Opportunities
    • Technological advancements in risk-based monitoring software
    • Rising trend of outsourcing end-to-end services by pharmaceutical companies
  • Market Challenges
    • Data security and privacy concerns associated with RBM software

Porter's Five Forces: A Strategic Tool for Navigating the Risk-based Monitoring Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Risk-based Monitoring Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Risk-based Monitoring Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Risk-based Monitoring Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Risk-based Monitoring Software Market

A detailed market share analysis in the Risk-based Monitoring Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Risk-based Monitoring Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Risk-based Monitoring Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Risk-based Monitoring Software Market, highlighting leading vendors and their innovative profiles. These include Anju Software, Inc., ArisGlobal LLC, CGI Inc., Change Healthcare LLC, Clario, CluePoints S.A., Dassault Systemes S.E., DATATRAK International, Inc., DSG, Inc., eClinical Solutions LLC, ICON PLC, Infosys Limited, International Business Machines Corporation, IQVIA Inc., JMP Statistical Discovery LLC, Laboratory Corporation of America Holdings, LexisNexis Risk Solutions Group, MasterControl Solutions Inc., Mednet, Microsoft Corporation, Octalsoft by Glorant, LLC, Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Scrut Automation, Securitas AB, Signant Health, Sphera Solutions, Inc., TATA Consultancy Services Limited, Veeva Systems Inc., and Wipro Limited.

Market Segmentation & Coverage

This research report categorizes the Risk-based Monitoring Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Function, market is studied across Centralized Monitoring, Reduced Monitoring, Remote Monitoring, and Triggered Monitoring.
  • Based on Delivery Mode, market is studied across Cloud-Based, Licensed Enterprise, and Web-Based.
  • Based on End-User, market is studied across Contract Research Organization, Medical Device Companies, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for proactive approach to monitoring clinical trials with the use of risk-based monitoring software
      • 5.1.1.2. Rising number of clinical trials to determine new form of treatment and effectiveness of drugs
      • 5.1.1.3. Government grants and regulatory compliance for the quality and safety of clinical trials
    • 5.1.2. Restraints
      • 5.1.2.1. Complex implementation of the RBM software and organization reluctance to RBM software
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in risk-based monitoring software
      • 5.1.3.2. Rising trend of outsourcing end-to-end services by pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Data security and privacy concerns associated with RBM software
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Function: Emergence of risk-based monitoring softwares for remote monitoring activities
    • 5.2.2. Delivery Mode: Advancements in cloud-based delivery of risk-based monitoring softwares
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Risk-based Monitoring Software Market, by Function

  • 6.1. Introduction
  • 6.2. Centralized Monitoring
  • 6.3. Reduced Monitoring
  • 6.4. Remote Monitoring
  • 6.5. Triggered Monitoring

7. Risk-based Monitoring Software Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. Cloud-Based
  • 7.3. Licensed Enterprise
  • 7.4. Web-Based

8. Risk-based Monitoring Software Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organization
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Risk-based Monitoring Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Risk-based Monitoring Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Risk-based Monitoring Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Cloudbyz Unveiled Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
    • 12.3.2. Clario Launched Cloud-Based Image Viewer for Clinical Trials
    • 12.3.3. ClinChoice Acquired CROMSOURCE, Expanding its Global Presence
    • 12.3.4. Scrut Automation Raised USD 7.5 Million From Massmutual Ventures
    • 12.3.5. EMA launched a pilot project on analysis of raw data from clinical trials
    • 12.3.6. Q2 Solutions Launched Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
    • 12.3.7. Medidata Announced Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators
    • 12.3.8. Medidata Launches New Clinical Operations Technologies to Address Critical Issues in Clinical Trial Oversight
    • 12.3.9. Novotech and Medidata expanded partnership to continue advancements in clinical research
    • 12.3.10. Veeva Vault CTMS Enabled Proactive Clinical Trial Management for More than 150 Companies
    • 12.3.11. TCS launches risk-based monitoring solution
    • 12.3.12. Thread and Amazon Web Services Modernized Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology

Companies Mentioned

  • 1. Anju Software, Inc.
  • 2. ArisGlobal LLC
  • 3. CGI Inc.
  • 4. Change Healthcare LLC
  • 5. Clario
  • 6. CluePoints S.A.
  • 7. Dassault Systemes S.E.
  • 8. DATATRAK International, Inc.
  • 9. DSG, Inc.
  • 10. eClinical Solutions LLC
  • 11. ICON PLC
  • 12. Infosys Limited
  • 13. International Business Machines Corporation
  • 14. IQVIA Inc.
  • 15. JMP Statistical Discovery LLC
  • 16. Laboratory Corporation of America Holdings
  • 17. LexisNexis Risk Solutions Group
  • 18. MasterControl Solutions Inc.
  • 19. Mednet
  • 20. Microsoft Corporation
  • 21. Octalsoft by Glorant, LLC
  • 22. Oracle Corporation
  • 23. Parexel International Corporation
  • 24. Quanticate International Limited
  • 25. Scrut Automation
  • 26. Securitas AB
  • 27. Signant Health
  • 28. Sphera Solutions, Inc.
  • 29. TATA Consultancy Services Limited
  • 30. Veeva Systems Inc.
  • 31. Wipro Limited